Provided by Tiger Trade Technology Pte. Ltd.

Jaguar Animal Health

0.3190
-0.0473-12.91%
Post-market: 0.32050.0015+0.47%17:01 EDT
Volume:749.88K
Turnover:241.65K
Market Cap:1.65M
PE:0.00
High:0.3669
Open:0.3669
Low:0.3096
Close:0.3663
52wk High:77.63
52wk Low:0.3096
Shares:5.17M
Float Shares:4.88M
Volume Ratio:0.82
T/O Rate:15.37%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-262.2873
EPS(LYR):-803.9466
ROE:-548.83%
ROA:-38.04%
PB:0.25
PE(LYR):0.00

Loading ...

Jaguar Health - Napo and Alivus Enter New Manufacturing and Supply Agreement for Crofelemer on July 9, 2026 - SEC Filing

THOMSON REUTERS
·
Jul 15

Jaguar Health - 2026 Agreement Set to Expire on March 31, 2029 - SEC Filing

THOMSON REUTERS
·
Jul 15

Jaguar Health Completes Series O Preferred Conversion into Common Shares at 3.209-to-1 Ratio

Reuters
·
Jul 02

Jaguar Health provides recap of presentations of crofelemer at ESPGHAN

TIPRANKS
·
Jun 30

Jaguar Health Says Pediatric Intestinal Failure Trial Data Show Crofelemer Cuts Parenteral Support Needs up to 48%

Reuters
·
Jun 30

Jaguar Animal Health Converts Series O Preferred to Common

TIPRANKS
·
Jun 25

Jaguar Health Triggers Conversion of Series O Preferred Shares into Common Stock at 3.209-to-1 Ratio

Reuters
·
Jun 25

Jaguar Health Files New Animal Drug Application For Full FDA Approval Of Canine Diarrhea Therapy

MT Newswires Live
·
Jun 23

Jaguar Health completes FDA submission seeking full approval of Canalevia-CA1 for dog chemo diarrhea

Reuters
·
Jun 23

Jaguar Health - Strategic Alternatives May Include Mergers, Acquisitions, Partnerships, or Licensing - SEC Filing

THOMSON REUTERS
·
Jun 22

Jaguar Health - Board Initiates Process to Explore Strategic Alternatives - SEC Filing

THOMSON REUTERS
·
Jun 22

Jaguar Health Explores Strategic Alternatives

MT Newswires Live
·
Jun 22

Jaguar Health CEO presents crofelemer rare intestinal failure update at Life Sciences Virtual Investor Forum

Reuters
·
Jun 22

Jaguar Health extends Streeterville promissory note maturity to Oct. 1, 2026

Reuters
·
Jun 19

Magdalena Biosciences announces results from preclinical study of coca

TIPRANKS
·
Jun 18

Red Light Holland reports positive preclinical mouse study for coca extract to prevent post-GLP-1 weight regain

Reuters
·
Jun 18

Jaguar Health joint venture reports preclinical study shows coca leaf extract prevents weight gain in mice

Reuters
·
Jun 18

Jaguar Health CEO to present at Life Sciences Virtual Investor Forum

Reuters
·
Jun 12

Jaguar Animal Health Secures New Equity and Preferred Funding

TIPRANKS
·
Jun 11

Jaguar Health - Enters Common Stock Purchase Agreement for up to $40 Mln - SEC Filing

THOMSON REUTERS
·
Jun 11